Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...
The company plans to resume its CATT1 Phase 3 trial for type 1 diabetes after submitting a protocol amendment.
Diabetes. 2006;55(1):1-12. Glucokinase is required for GSIR in the physiological range of 4-8 mmol/l. Glucokinase is needed for amino acid and fatty acid stimulation of insulin release.
Magnesium regulates an enzyme known as glucokinase, responsible for converting glucose into glucose-6-phosphate. Type 2 ...
Glucokinase-MODY and HNF1A-MODY are the two most common subtypes of MODY. A mild subtype of MODY, glucokinase-MODY, might remain undiagnosed for decades, as the symptoms are generally mild or ...